Danaher Corp

DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3027% above fair value

$232.23−4.75 (-2.00%)

Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –

Danaher OpenFDA by Quarter

Name: Danaher OpenFDA by Quarter (DHR)
Creator: Danaher

openFDA — Total FDA 510(k) Medical Device Clearances for the Danaher Ecosystem (Monthly / Quarterly / Annual)

Quarterly Annual Monthly

Danaher OpenFDA: 8 in Q3 2026, up 14.3% from a year earlier.

Latest, Q3 2026

Period ended Sep 30, 2026

Change on a year earlier

+14.3%

7 in Q3 2025

History

47 quarters

Since Q1 2015

Sources

U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE)

Where the Q3 2026 figure comes from

Source: U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗

Independent data from the openFDA database (updated monthly through 09/2026) measuring the pace of new diagnostic/medical device product launches by Danaher subsidiaries in the U.S. market.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	openFDA — Total FDA 510(k) Medical Device Clearances for the Danaher Ecosystem (Monthly / Quarterly / Annual)	Year on year	Source
Q3 2026	Sep 30, 2026	8	+14.3%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q2 2026	Jun 30, 2026	4	-20.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q1 2026	Mar 31, 2026	8	+14.3%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q4 2025	Dec 31, 2025	1	-83.3%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q3 2025	Sep 30, 2025	7	0.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q2 2025	Jun 30, 2025	5	-54.5%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q1 2025	Mar 31, 2025	7	0.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q4 2024	Dec 31, 2024	6	-25.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q3 2024	Sep 30, 2024	7	-36.4%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q2 2024	Jun 30, 2024	11	+175.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q1 2024	Mar 31, 2024	7	-12.5%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q4 2023	Dec 31, 2023	8	+166.7%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q3 2023	Sep 30, 2023	11	+1,000.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q2 2023	Jun 30, 2023	4	0.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q1 2023	Mar 31, 2023	8	+166.7%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q4 2022	Dec 31, 2022	3	+200.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q3 2022	Sep 30, 2022	1	0.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q2 2022	Jun 30, 2022	4	+33.3%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q1 2022	Mar 31, 2022	3	+200.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q4 2021	Dec 31, 2021	1	-50.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q3 2021	Sep 30, 2021	1	-83.3%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q2 2021	Jun 30, 2021	3	0.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q1 2021	Mar 31, 2021	1	-75.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q4 2020	Dec 31, 2020	2	-50.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q3 2020	Sep 30, 2020	6	+200.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q2 2020	Jun 30, 2020	3	-50.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q1 2020	Mar 31, 2020	4	-50.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q4 2019	Dec 31, 2019	4	+33.3%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q3 2019	Sep 30, 2019	2	-33.3%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q2 2019	Jun 30, 2019	6	+100.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q1 2019	Mar 31, 2019	8	+166.7%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q4 2018	Dec 31, 2018	3	-50.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q3 2018	Sep 30, 2018	3	-25.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q2 2018	Jun 30, 2018	3	-40.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q1 2018	Mar 31, 2018	3	-40.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q4 2017	Dec 31, 2017	6	0.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q3 2017	Sep 30, 2017	4	+33.3%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q2 2017	Jun 30, 2017	5	0.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q1 2017	Mar 31, 2017	5	+25.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q4 2016	Dec 31, 2016	6	+100.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q3 2016	Sep 30, 2016	3	+200.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q2 2016	Jun 30, 2016	5	+66.7%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q1 2016	Mar 31, 2016	4	+100.0%	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q4 2015	Dec 31, 2015	3	–	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q3 2015	Sep 30, 2015	1	–	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q2 2015	Jun 30, 2015	3	–	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Q1 2015	Mar 31, 2015	2	–	U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗

Breakdown

What makes up openFDA

Cite this data

StockData. (2026). Danaher OpenFDA, quarterly Q1 2015–Q3 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-fda-510k-dhr-total

See every metric in the Danaher KPI table. Data updated Nov 2, 2026.